These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Drug therapy for peptic ulcer: drugs that act on the gastric mucosa. Kauffman GL. J Clin Gastroenterol; 1981 Feb; 3(Suppl 2):95-101. PubMed ID: 6119340 [Abstract] [Full Text] [Related]
23. [H2 receptor antagonists in the therapy of peptic ulcer disease]. Dammann HG, Dau B, Dreyer M, Müller P, Simon B. Z Gastroenterol; 1987 Aug; 25 Suppl 3():136-45. PubMed ID: 2889298 [Abstract] [Full Text] [Related]
24. [Peptic ulcer: a social and therapeutic problem still current]. Visconti GP, Spotti D, Vigorelli PE, Geniram A. Recenti Prog Med; 1979 Nov; 67(5):530-45. PubMed ID: 42955 [No Abstract] [Full Text] [Related]
25. Study of outcome after targeted intervention for peptic ulcer resistant to acid suppression therapy. Lanas A, Remacha B, Sáinz R, Hirschowitz BI. Am J Gastroenterol; 2000 Feb; 95(2):513-9. PubMed ID: 10685760 [Abstract] [Full Text] [Related]
26. The treatment of dyspepsia. Shearman DJ. Aust Fam Physician; 1977 Aug; 6(8):1028-32. PubMed ID: 921613 [Abstract] [Full Text] [Related]
27. [Medical therapy of peptic ulcer: problems and prospects]. Trabucchi E, Foschi D, Belloli P, Montorsi F, Marchetti V, Mariscotti C, Diamantini S. Minerva Dietol Gastroenterol; 1989 Aug; 35(1):1-6. PubMed ID: 2566959 [Abstract] [Full Text] [Related]
28. [A comparative evaluation of the efficacy of sucralfate and H2-histamine blockaders in treating peptic ulcer]. Ivashkin VT, Tkachenko EI, Grinevich VB, Sultanov VK, Inozemtsev SA. Ter Arkh; 1989 Aug; 61(8):59-62. PubMed ID: 2573963 [Abstract] [Full Text] [Related]
30. Endoscopic appearances of hemorrhagic peptic ulcers and efficacy of H2-receptor antagonists. Fusamoto H, Kawano S, Tsuji S, Oshita M, Nagano K, Ohmae A, Sawaoka H, Nagai Y, Kasahara A, Sugimoto T, Kamada T. Hepatogastroenterology; 1996 Nov; 43(7):169-73. PubMed ID: 8682457 [Abstract] [Full Text] [Related]
31. [Antacids and muscarinic and histamine H2 receptor blockaders in the treatment of peptic ulcer]. Ivashkin VT, Minasian GA. Klin Med (Mosk); 1987 Jan; 65(1):24-31. PubMed ID: 2882061 [No Abstract] [Full Text] [Related]
32. Symposium on peptic ulcer disease. 1. Medical treatment of peptic ulcer. Jeejeebhoy KN. Can J Surg; 1978 Jan; 21(1):17-8. PubMed ID: 579607 [Abstract] [Full Text] [Related]
33. Pharmacologic options for the control of peptic ulcer disease. Levine JB. Adv Intern Med; 1984 Jan; 30():425-47. PubMed ID: 6152108 [No Abstract] [Full Text] [Related]
34. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs. McCarthy DM. Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039 [Abstract] [Full Text] [Related]
35. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs. Pilotto A, Franceschi M, Leandro G, Paris F, Cascavilla L, Longo MG, Niro V, Andriulli A, Scarcelli C, Di Mario F. Aliment Pharmacol Ther; 2004 Nov 15; 20(10):1091-7. PubMed ID: 15569111 [Abstract] [Full Text] [Related]
36. [Drug therapy of peptic ulcer in the elderly]. Koop H. Z Gerontol; 1992 Nov 15; 25(5):304-8. PubMed ID: 1359717 [Abstract] [Full Text] [Related]
37. Short- and long-term management of peptic ulcer disease: current role of H2-antagonists. Brooks WS. Hepatogastroenterology; 1992 Feb 15; 39 Suppl 1():47-52. PubMed ID: 1349553 [Abstract] [Full Text] [Related]